Analgesia iv vs Epidural Analgesia vs Port-sites Infiltration After Laparoscopic Sleeve Gastrectomy

H

Hospital General Universitario Elche

Status and phase

Completed
Phase 3

Conditions

Postoperative Pain

Treatments

Drug: Metamizole and Acetaminophen iv
Drug: Epidural analgesia:Levobupivacaine0,125%
Drug: Port-sites infiltration:Bupivacaine0.25%

Study type

Interventional

Funder types

Other

Identifiers

NCT02662660
HGUE 16-03

Details and patient eligibility

About

A prospective randomized study of patients undergoing laparoscopic sleeve gastrectomy between 2012 and 2015 will be performed. Patients will be divided into 3 groups: Analgesia iv exclusively (Group 1), epidural analgesia+analgesia iv (Group 2) and port-sites infiltration+analgesia iv (Group 3). Pain will be quantified by means of a Visual Analogic Scale and morphine rescue needs were determined 24 hours after surgery.

Full description

A prospective randomized study of patients undergoing laparoscopic sleeve gastrectomy between 2012 and 2015 will be performed. Patients will be randomized using a computerized simple randomization scheme in a 1:1:1 ratio into 3 groups: those patients receiving only intravenous analgesia (Group 1), those ones receiving intravenous analgesia associated to epidural analgesia (Group 2) and those patients receiving intravenous analgesia associated with port-sites infiltration with bupivacaine. Pain quantification as measured by Visual Analogic Scale (VAS), ranging from 0 (absence of pain) to 10 (unbearable pain) will be evaluated 24 hours after surgery.

Enrollment

147 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • body mass index (BMI) >40 Kg/m2
  • BMI > 35 Kg/m2 with the presence of comorbidities associated to obesity

Exclusion criteria

  • patients undergoing other bariatric techniques
  • severe underlying cardiovascular diseases
  • chronic renal failure
  • hepatic dysfunction
  • previous foregut surgery
  • patients with any contraindication for bariatric surgery

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

147 participants in 3 patient groups

Port-sites infiltration:Bupivacaine0,25%
Experimental group
Description:
Port-sites infiltration will be performed with 10 ml of Bupivacaine 0.25%, applying 2 ml under the aponeurotic layer in each port. Associated intravenous analgesia will include Metamizole 2g/8h and Acetaminophen 1g/8h, alternating every 4 hours.
Treatment:
Drug: Port-sites infiltration:Bupivacaine0.25%
Drug: Metamizole and Acetaminophen iv
Epidural analgesia:Levobupivacaine0.125%
Experimental group
Description:
Epidural analgesia consists in the placement of a thoracic epidural catheter inserted at the level T6-T7 and administration of a continuous perfusion of Levobupivacaine 0.125% 6ml/h. Associated intravenous analgesia will include Metamizole 2g/8h and Acetaminophen 1g/8h, alternating every 4 hours.
Treatment:
Drug: Metamizole and Acetaminophen iv
Drug: Epidural analgesia:Levobupivacaine0,125%
Metamizole and Acetaminophen iv
Active Comparator group
Description:
Associated intravenous analgesia will include Metamizole 2g/8h and Acetaminophen 1g/8h, alternating every 4 hours.
Treatment:
Drug: Metamizole and Acetaminophen iv

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems